-+ 0.00%
-+ 0.00%
-+ 0.00%

MBX Biosciences Q4 EPS $(0.49) Beats $(0.68) Estimate

Benzinga·03/12/2026 12:14:00
Listen to the news
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.68) by 27.84 percent. This is a 4.26 percent decrease over losses of $(0.47) per share from the same period last year.